| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.05. | How I Learned To Trust AI as a Physical Therapist | ||
| 05.05. | Kidney Care Is Value-Based Care's Toughest Economic Test - and It's Working | ||
| 05.05. | Healthcare Doesn't Have an AI Problem - It Has a Readiness Problem | ||
| 05.05. | Is the Atrium-WakeMed Merger Already Hitting a Wall? | ||
| 04.05. | UCB Joins the Chase for Immune System Reset With $2B Acquisition | ||
| 04.05. | Why EHRs Are Critical to Effective Revenue Cycle Management | ||
| 04.05. | The Behavioral Health Workforce Crisis: Administrative Burden Is Breaking Your Nursing Team | ||
| 04.05. | Sleep Is the Missing Vital Sign, and Health AI Is Scaling the Consequences | ||
| 04.05. | Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026 | ||
| 04.05. | The Power of Real World Data to Study Women's Health at Scale | ||
| 03.05. | Four Biotech IPOs Raise $1.5B in April, the Biggest Month in Five Years | ||
| 03.05. | Why the CVS-Mass General Deal Would Likely Increase Spending More Than Access | ||
| 03.05. | The Evolving Medical Practice: How Doctors Can Adapt and Prosper In a Changing Environment | ||
| 03.05. | The Biosimilar Market Isn't Failing, It's Finding Its Purpose | ||
| 03.05. | The AI Funding Divide: Why VCs Will Miss the Next Healthcare Category Kings (And Where CEOs Should Look Instead) | ||
| 01.05. | Move Over Doximity - There's a New Social Network for Doctors | ||
| 01.05. | Axsome Drug's FDA Approval Unlocks New Opportunity in Alzheimer's Agitation | ||
| 01.05. | Why Clinical Digital Out-of-Home Displays Are Healthcare's Most Untapped Advertising Opportunity | ||
| 01.05. | The Multimodal Explosion: Why 2026 Breaks the AI Paradigm | ||
| 01.05. | Why Metabolic Health Is a Common Thread Across Diabetes, Heart Disease, and Some Cancer | ||
| 01.05. | Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs | ||
| 01.05. | Will Tennessee's PBM Bill Face the Same Fate as Arkansas' Law? | ||
| 30.04. | MedCity FemFwd: Inside Partum Health's Partnership with UChicago Medicine | ||
| 30.04. | Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials | ||
| 30.04. | Why Protocol Complexity Keeps Increasing - and How to Fix It |